Name: Initial public offering of Genticel on Euronext Paris
Uploaded: 2014-04-04T09:58:15+0200
Description: Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris. Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.

搜索联络表

This page is available in multiple languages

Select Language

Back

04/04/2014

Playing this video will load a content from YouTube, a service of Google LLC. For information on how Google may use your data, see the Google privacy policy.

Accept cookies

Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris.

Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.